Despite secondary prevention with oral anticoagulation (OAC), the risk for recurrent ischemic stroke (IS) and mortality is high in patients with atrial fibrillation (AF). However, OAC discontinuation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback